Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology – A new chance for causative therapy?
Jonas Groner, Achim Goepferich, Miriam Breunig
Topics & Concepts
MedicineDrug deliveryTargeted drug deliveryMacrophagePharmacologyCause of deathDiseaseInflammationDrugNanotechnologyChemistryImmunologyPathologyMaterials scienceBiochemistryIn vitroAtherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular HealthSystemic Lupus Erythematosus Research